The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.
Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
Open accessAbstract
Neuroinflammation constitutes a fundamental process involved in the progression of several neurodegenerative disorders, such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis and multiple sclerosis. Microglial cells play a central role in neuroinflammation, promoting neuroprotective or neurotoxic microenvironments, thus controlling neuronal fate. Acquisition of different microglial functions is regulated by intercellular interactions with neurons, astrocytes, the blood-brain barrier, and T-cells infiltrating the central nervous system. In this study, an overview of the regulation of microglial function mediated by different intercellular communications is summarised and discussed. Afterward, we focus in T-cell-mediated regulation of neuroinflammation involved in neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglial cells express these receptors (TLR1-TLR9) and their co-receptors, which promote microglial activation (Gonzalez et al., 2014).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Gonzalez et al., 2014
In the citing paper
“M1 microglial cells present amoeboid morphology as well as high phagocytic capacity and motility (Varnum and Ikezu, 2012; Gonzalez et al., 2014; Jones and Bouvier, 2014).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Gonzalez et al., 2014
Citations
Cites
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Cited by
Sorted by citations
Items 101–200 of 353
Zou, Z., Chen, J., Feng, H.-F., Cheng, Y., Wang, H., Zhou, Z., Guo, H., Zheng, W., & Xu, J. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239608 · Cited by 55
The pathogenesis of bornaviral diseases in mammals
Tizard, I. R., Ball, J. M., Stoica, G., & Payne, S. (2016) · Animal Health Research Reviews · doi:10.1017/s1466252316000062 · Cited by 54
The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer’s disease
Giorgi, F. S., Saccaro, L. F., Galgani, A., Busceti, C. L., Biagioni, F., Frati, A., & Fornai, F. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.007 · Cited by 53
Myeloid derived suppressor cells in inflammatory conditions of the central nervous system
Melero‐Jerez, C., Ortega, M. C., Moliné-Velázquez, V., & Clemente, D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.015 · Cited by 50
Xu, E., Liu, J., Liu, H., Wang, X., & Xiong, H. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9780-y · Cited by 52
Developmental roles of microglia: A window into mechanisms of disease
Anderson, S., & Vetter, M. L. (2018) · Developmental Dynamics · doi:10.1002/dvdy.1 · Cited by 53
Nitric Oxide Inhibitory Meroterpenoids from the Fungus Penicillium purpurogenum MHZ 111
Sun, J., Zhu, Z., Song, Y., Dong, D., Zheng, J., Liu, T., Zhao, Y., Ferreira, D., Zjawiony, J. K., Tu, P., et al. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00160 · Cited by 49
Demane, D. F., Contreras, F., González, H., Prado, C. E., Elgueta, D., Figueroa, C. A., & Pacheco, R. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.05.003 · Cited by 49
Mechanisms of long-term cognitive dysfunction of sepsis: from blood-borne leukocytes to glial cells
Michels, M., Steckert, A. V., Quevedo, J., Barichello, T., & Dal‐Pizzol, F. (2015) · Intensive Care Medicine Experimental · doi:10.1186/s40635-015-0066-x · Cited by 48
Fellner, A., Barhum, Y., Angel, A., Perets, N., Steiner, I., Offen, D., & Lev, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081666 · Cited by 48
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Reich, N., & Hölscher, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614828 · Cited by 48
“Over time, prolonged neuroinflammation encourages various other secondary complications, such as impairments in protein degradation, amyloid misfolding, Tau hyperphosphorylation (in conjunction with the inflammationperpetuating activation of the inflammasome), permeabilization of the BBB, peripheral immune cell infilt…”
BackgroundBrimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage
Conti, F., Romano, G. L., Eandi, C. M., Toro, M. D., Ręjdak, R., Benedetto, G. D., Lazzara, F., Bernardini, R., Drago, F., Cantarella, G., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.705405 · Cited by 48
The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives
Casallas, J. C. G., & Bustos, R. (2018) · Brain Sciences · doi:10.3390/brainsci8120222 · Cited by 49
Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways
Mowry, F. E., & Biancardi, V. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.029 · Cited by 45
Immune-mediated processes in neurodegeneration: where do we stand?
Fakhoury, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8052-0 · Cited by 43
Sarkar, S. N., Russell, A. E., Engler-Chiurazzi, E. B., Porter, K. N., & Simpkins, J. W. (2018) · Aging and Disease · doi:10.14336/ad.2018.0409 · Cited by 43
Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells
Bozic, I. D., Savić, D. Z., Stevanović, I. D., Peković, S., Nedeljković, N., & Lavrnja, I. C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00351 · Cited by 44
Neuroimmune Signaling: Cytokines and the CNS
Kennedy, R. H., & Silver, R. (2015) · Springer eBooks · doi:10.1007/978-1-4614-6434-1_174-1 · Cited by 41
Pellegrini, C., Colucci, R., Antonioli, L., Barocelli, E., Ballabeni, V., Bernardini, N., Blandizzi, C., de Jonge, W. J., & Fornai, M. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12933 · Cited by 41
Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad
Ge, Y., Cheng, D., Jia, Q., Xiong, H., & Zhang, J. (2021) · Immune Network · doi:10.4110/in.2021.21.e21 · Cited by 39
Salmani, H., Hosseini, M., Beheshti, F., Baghcheghi, Y., Sadeghnia, H., Soukhtanloo, M., Shafei, M., & Khazaei, M. (2018) · Life Science · doi:10.1016/j.lfs.2018.04.033 · Cited by 36
Nuciferine inhibits LPS-induced inflammatory response in BV2 cells by activating PPAR-γ
Zhang, L., Gao, J., Tang, P., Li, C., Liu, Y., Liu, P., Zhang, X., Chen, L., & Hou, C. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.07.015 · Cited by 40
Zhang, L., & Chen, J. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3641960 · Cited by 40
Falcão, A. S., Carvalho, L. A. R., Lidónio, G. M. D. C., Vaz, A. R., Lucas, S. D., Moreira, R., & Brites, D. M. T. O. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00250 · Cited by 38
Klegeris, A., Madeira, J., & Schindler, S. M. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.153686 · Cited by 36
Orłowski, D., Michalis, A., Glud, A. N., Korshoej, A. R., Fitting, L. M., Mikkelsen, T. W., Mercanzini, A., Jordan, A., Dransart, A., & Sørensen, J. C. H. (2017) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12576 · Cited by 37
Wang, R., Zhang, Z., Kumar, M., Xu, G., & Zhang, M. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s188636 · Cited by 36
Zhu, M., Liu, Z., Guo, Y., Sultana, S., Wu, K., Lang, X., Lv, Q., Huang, X., Yi, Z., & Li, Z. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02261-5 · Cited by 36
Bañuelos‐Cabrera, I., Valle-Dorado, M. G., Aldana, B. I., Orozco-Suárez, S. A., & Rocha, L. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.010 · Cited by 36
Role of hypoxia-inducible factor-1α in autophagic cell death in microglial cells induced by hypoxia
Wang, X., Ma, J., Fu, Q., Zhu, L., Zhang, Z., Zhang, F., Lü, N., & Chen, A. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6277 · Cited by 35
de Almeida, M. M. A., Souza, C. D. S., Dourado, N. S., da Silva, A. B., Ferreira, R. S., David, J. M., David, J. P., Costa, M. D. F. D., da Silva, V. D. A., Butt, A. M., et al. (2020) · Biomolecules · doi:10.3390/biom10040562 · Cited by 35
Liu, Y.-C., Feng, N., Li, W., Tu, P., Chen, J., Han, J., & Zeng, K. (2020) · Molecules · doi:10.3390/molecules25122840 · Cited by 36
Akintunde, J. K., Akintola, T. E., Adenuga, G., Odugbemi, Z. A., Adetoye, R. O., & Akintunde, O. G. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.08.001 · Cited by 35
New Insights into the Role of Cysteine Cathepsins in Neuroinflammation
Pišlar, A. H., Bolčina, L., & Kos, J. (2021) · Biomolecules · doi:10.3390/biom11121796 · Cited by 42
Are Microglial Cells the Regulators of Lymphocyte Responses in the CNS?
Almolda, B., González, B., & Castellano, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00440 · Cited by 34
Balaji, S. P., Chand, C. V., Justin, A., & Ramanathan, M. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.08.007 · Cited by 34
Restoring the oxidative balance in age-related diseases – An approach in glaucoma
Cáceres‐Vélez, P. R., Hui, F., Hercus, J., Bui, B. V., & Jusuf, P. R. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101572 · Cited by 35
In VivoMRI of Functionalized Iron Oxide Nanoparticles for Brain Inflammation
Tang, T., Valenzuela, A. E., Petit, F., Chow, S. S. L., Leung, K. H., Gorin, F. A., Louie, A. Y., & Dhénain, M. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/3476476 · Cited by 35
Shi, Z., Chen, Y., Lu, C., Dong, L.-M., Lv, J.-W., Tuo, Q.-H., Qin, L., Cheng, S.-W., Bu, L.-L., Lin, N., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.002 · Cited by 32
Systems‐level thinking for nanoparticle‐mediated therapeutic delivery to neurological diseases
Curtis, C., Zhang, M., Liao, R., Wood, T. R., & Nance, E. A. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1422 · Cited by 32
Brody, A. L., Gehlbach, D. L., Garcia, L. Y., Enoki, R., Hoh, C. K., Vera, D. R., Kotta, K. K., London, E. D., Okita, K., Nurmi, E. L., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5077-3 · Cited by 32
Bhuiyan, P., Chen, Y., Karim, M., Dong, H., & Qian, Y. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.010 · Cited by 33
Targeting Insulin for Alzheimer’s Disease: Mechanisms, Status and Potential Directions
Lee, J. H., Jahrling, J. B., Denner, L. A., & Dineley, K. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179923 · Cited by 36
Asatryan, L., Khoja, S., Rodgers, K. E., Alkana, R. L., Tsukamoto, H., & Davies, D. L. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.06.007 · Cited by 31
Hadar, A., Milanesi, E., Squassina, A., Niola, P., Chillotti, C., Pasmanik-Chor, M., Yaron, O., Pavel Martasek, E., Rehavi, M., Weissglas‐Volkov, D., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.179 · Cited by 31
Jiao, F., Wang, Y., Zhang, H., Zhang, W., Wang, L.-W., & Gong, Z. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2532-9 · Cited by 32
Báez-Jurado, E., Guio-Vega, G. P., Hidalgo‐Lanussa, O., González, J., Echeverrı́a, V., Ashraf, G. M., Sahebkar, A., & Barreto, G. E. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1442-9 · Cited by 29
Alokam, R., Singhal, S. M., Srivathsav, G., Garigipati, S., PSusrutha, S. P. M. S. R. C., Sriram, D., & Yogeeswari, P. (2014) · Molecular BioSystems · doi:10.1039/c4mb00570h · Cited by 29
The additive effect of aging on sepsis-induced cognitive impairment and neuroinflammation
Olivieri, R., Michels, M., Pescador, B., Ávila, P. R. M., Abatti, M. R., Cucker, L., Burger, H., Dominguini, D., Quevedo, J., & Dal‐Pizzol, F. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.11.014 · Cited by 29
Xie, A., Wang, J., Zhang, X., Fang, J.-N., Hua, F.-F., Han, J.-Y., & Yuan, Z. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.323077 · Cited by 28
Wang, C., Dai, S., Gong, L., Fu, K., Ma, C., Liu, Y., Zhou, H., & Li, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.791214 · Cited by 28
Carata, E., Muci, M., Giulio, S. D., Mariano, S., & Panzarini, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411251 · Cited by 30
Ye, S., Zhou, T., Cheng, K., Chen, M., Wang, Y., Jiang, Y., & Yang, P. (2015) · Nanoscale Research Letters · doi:10.1186/s11671-015-0953-9 · Cited by 28
Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages
Valente, T., Serratosa, J., Perpiñá, U., Saura, J., & Solà, C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00129 · Cited by 27
Fernández‐Albarral, J. A., de Hoz, R., Matamoros, J. A., Chen, L., López‐Cuenca, I., Salobrar‐García, E., Sánchez-Puebla, L., Ramirez, J. M., Triviño, A., Salazar, J. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10050939 · Cited by 26
Reiber, H., Kruse-Sauter, H., & Quentin, C. D. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.11.013 · Cited by 26
Sulforaphane mitigates LPS-induced neuroinflammation through modulation of Cezanne/NF-κB signalling
Wang, Z., Chen, Q., Wang, J., Yu, L., & Chen, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118519 · Cited by 26
Insulin resistance in the retina: possible implications for certain ocular diseases
Zheng, Z., & Yu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1415521 · Cited by 27
Horimoto, A. R. V. R., Xue, D., Thornton, T. A., & Blue, E. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00866-9 · Cited by 26
Interleukin 22 and its association with neurodegenerative disease activity
Chen, W., Wang, J., Yang, H., Sun, Y., Chen, B., Liu, Y., Han, Y., Shan, M., & Zhan, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.958022 · Cited by 27
Purine Signaling and Microglial Wrapping
Castellano, B., Bosch-Queralt, M., Almolda, B., Villacampa, N., & González, B. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7_7 · Cited by 25
Effect of long-term particulate matter exposure on Parkinson’s risk
Wang, Y., Liu, Y., & Yan, H. (2020) · Environmental Geochemistry and Health · doi:10.1007/s10653-019-00484-3 · Cited by 24
Myeloid cells in retinal and brain degeneration
Guo, M., Schwartz, T. D., Dunaief, J. L., & Cui, Q. N. (2021) · FEBS Journal · doi:10.1111/febs.16177 · Cited by 25
Blood Biomarkers in Patients with Parkinson’s Disease: A Review in Context of Anesthetic Care
Joo, J. D., Jeong, J., & Park, H. J. (2023) · Diagnostics · doi:10.3390/diagnostics13040693 · Cited by 22
Carvedilol abrogates hypoxia-induced oxidative stress and neuroinflammation in microglial BV2 cells
Gao, X., Wu, B., Fu, Z., Zhang, Z., & Xu, G. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.013 · Cited by 22
POSTOPERATIVE COGNITIVE DYSFUNCTION – WHAT WE KNOW AND WHERE WE GO
Polushin, Y. S., Polushin, A. Y., Yukina, G. Y., & Kozhemyakina, M. V. (2019) · Messenger of Anesthesiology and Resuscitation · doi:10.21292/2078-5658-2019-16-1-19-28 · Cited by 22
de Oliveira, M. R., Brasil, F. B., & Fürstenau, C. R. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01339-3 · Cited by 22
Mahmoudiasl, G., Abbaszadeh, H., Rezaei–Tavirani, M., Abdollahifar, M., Khoramgah, M. S., Niknazar, S., Darabi, S., & Roozbahany, N. A. (2019) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2019_129 · Cited by 22
Pathogenesis of cerebral toxocariasis and neurodegenerative diseases
Fan, C. (2020) · Advances in Parasitology/Advances in parasitology · doi:10.1016/bs.apar.2020.01.008 · Cited by 24
LEI, L.-Y., WANG, R.-C., PAN, Y.-L., YUE, Z.-G., ZHOU, R., XIE, P., & TANG, Z.-S. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60012-2 · Cited by 39
Mechanisms of action of intravenous immunoglobulin in septic encephalopathy
Esen, F., Özcan, P. E., Tüzün, E., & Boone, M. D. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0065 · Cited by 21
Astrocyte phenotypes: Emphasis on potential markers in neuroinflammation.
Bozic, I. D., Savić, D. Z., & Lavrnja, I. C. (2021) · PubMed · doi:10.14670/hh-18-284 · Cited by 22
Childs, R., Gamage, R. V., Münch, G. W., & Gyengési, E. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135807 · Cited by 22
Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders
Miller, S., & Blanco, M.-J. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00036e · Cited by 21
Ranjbaran, M., Kianian, F., Ashabi, G., Lorian, K., & Azizi, F. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02374-5 · Cited by 21
Wang, M., Zhi, D., Wang, H., Ru, Y., Ren, H. J., Wang, N., Liu, Y., Li, Y., & Li, H. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7251-4 · Cited by 21
Autism and Our Intestinal Microbiota
Reddy, B. L., & Saier, M. H. (2015) · Microbial Physiology · doi:10.1159/000375303 · Cited by 21
Ravenhill, S. M., Evans, A. H., & Crewther, S. G. (2023) · Antioxidants · doi:10.3390/antiox12051117 · Cited by 22
Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis
Kostić, M. S., Živković, N., Cvetanović, A., & Stojanović, I. R. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.002 · Cited by 21
Velkovska, M. A., Goričar, K., Blagus, T., Dolžan, V., & Cvenkel, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051148 · Cited by 21
Yan, J., Sun, J., Zhai, M.-M., Cheng, L.-N., Bai, X., & Feng, C. (2015) · Europe PMC (PubMed Central) · Cited by 20
Goyal, A., Gopika, S., Kumar, A., & Garabadu, D. (2022) · Current Drug Targets · doi:10.2174/1389450123666220316091734 · Cited by 20
Qin, N., Li, S.-G., Yang, X., Gong, C., Zhang, X., Wang, J., Li, D., Guo, Y., Li, Z., & Hua, H. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.058 · Cited by 19
Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Gambino, C. M., Sasso, B. L., Bivona, G., Agnello, L., & Ciaccio, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191112093034 · Cited by 19
Mazloumfard, F., Mirian, M., Eftekhari, S.-M., & Aliomrani, M. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00609-z · Cited by 19
HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis
Hu, A., Zaongo, S. D., Harypursat, V., Wang, X., Ouyang, J., & Chen, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1428239 · Cited by 18
Venkanna, A., Cho, K. H., Dhorma, L. P., Kumar, D. N., Hah, J.-M., Park, H., Kim, S. Y., & Kim, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.037 · Cited by 18
Dai, D., He, L., Chen, Y., & Zhang, C. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.013 · Cited by 20
Poly(ADP-ribosylated) proteins in β-amyloid peptide-stimulated microglial cells
Correani, V., Martire, S., Mignogna, G., Caruso, L. B., Tempera, I., Giorgi, A., Grieco, M., Mosca, L., Schininà, M. E., Maras, B., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.026 · Cited by 19
NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction
Xu, L., Qiu, X., Wang, S., Wang, Q., & Zhao, X. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0321-8 · Cited by 17
Salmani, H., Hosseini, M., Baghcheghi, Y., & Noshahr, Z. S. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00141-y · Cited by 16
Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity
Prado, C. E., Osorio‐Barrios, F., Falcón, P., Espinoza, A., Sáez, J. J., Yuseff, M.-I., & Pacheco, R. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02338-1 · Cited by 17
Zhuo, Y., Li, X., He, Z., & Lu, M. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03280-0 · Cited by 17
Asejeje, F. O., Abiola, M. A., Adeyemo, O. A., Ogunro, O. B., & Ajayi, A. M. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137710 · Cited by 18
Direct immunomodulatory influence of IFN- β on human astrocytoma cells
Mohsenzadegan, M., Fayazi, M. R., Abdolmaleki, M., Bakhshayesh, M., Seif, F., & Mousavizadeh, K. (2015) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1014559 · Cited by 17
Asghari, A., Hosseini, M., Beheshti, F., Shafei, M. N., & Mehri, S. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1480602 · Cited by 17
Dynamic glial response and crosstalk in demyelination-remyelination and neurodegeneration processes
Shields, C. B., Cai, J., Chu, T., Shields, L. B. E., Zeng, W., Zhang, Y., Wang, Y., & Barnes, G. N. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300975 · Cited by 21
Tissue-resident immune cells in the pathogenesis of multiple sclerosis
Tian, J., Jiang, L., Chen, Z.-X., Yuan, Q., Liu, C., He, L., Jiang, F., & Rui, K. (2022) · Inflammation Research · doi:10.1007/s00011-022-01677-w · Cited by 18
Levtova, N., Healy, L. M., Gonczi, C. M. C., Stopnicki, B., Blain, M., Kennedy, T. E., Moore, C. S., Antel, J. P., & Darlington, P. J. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.05.012 · Cited by 17
El‐Bakly, W. M., Wagdy, O., Sobhy, A., elenain, O. A., Riad, M. S., Sayed, M., Tarkhan, S., Yassen, M., Mahmoud, A., Bassiony, M. A. A., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112004 · Cited by 17
Metadata
- Authors
- González, H., Elgueta, D., Montoya, A., & Pacheco, R.
- Affiliations
- Fundación Ciencia and Vida (CL)
- Universidad Andrés Bello (CL)
- Universidad San Sebastián (CL)
- Corresponding author
- Pacheco, Rodrigo
- Venue
- Journal of Neuroimmunology
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 274
- Issue
- 1-2
- Pages
- 1-13
- ISSN
- 0165-5728 (ISSN-L)
- OpenAlex
- W2003129702
- Cited by
- 352
- References
- 150
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 24 · 2023: 24 · 2022: 19 · 2021: 45 · 2020: 34 · 2019: 38 · 2018: 46 · 2017: 30 · 2016: 28 · 2015: 33 · 2014: 6
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- Locations
- Journal of Neuroimmunology (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- FONDECYT (1130271)
- CONICYT (PFB-16)
- Universidad San Sebastián (2011-0001-R)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- microglia, neuroinflammation, neurodegenerative diseases, neuroimmune regulation, microglial activation, intercellular communication, microglia-neuron interaction, blood-brain barrier, T cell infiltration, Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis
- MeSH terms
- Animals, Blood-Brain Barrier, Humans, Immune Tolerance, Neuritis, Neuroimmunomodulation, Microglia, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review